Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 16.

Journal Article

Gaidano, G., Platzbecker, U., Kreuzer, K. -A., Bernal de Castillo, T., Silverman, L., Garcia-Manero, G., Loferer, H. and Fenaux, P. (2015). SUBGROUP ANALYSES OF A PHASE 3 STUDY IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES FAILING HMA TREATMENT: IDENTIFICATION OF A HOMOGENEOUS POPULATION WHO BENEFIT FROM RIGOSERTIB THERAPY. Haematologica, 100. S. 491 - 493. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Garcia-Manero, G., Fenaux, P., Al-Kali, A., Baer, M., Sekeres, M., Roboz, G., Gaidano, G., Scott, B., Greenberg, P., Platzbecker, U., Steensma, D., Kreuzer, K. -A., Godley, L., Collins, R., Atallah, E., Azarnia, N. and Silverman, L. (2015). OVERALL SURVIVAL (OS) AND BASELINE DISEASE CHARACTERISTICS IN MDS PATIENTS WITH PRIMARY HMA FAILURE IN A RANDOMIZED, CONTROLLED, PHASE III STUDY OF RIGOSERTIB. Haematologica, 100. S. 238 - 239. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Garcia-Manero, G., Fenaux, P., Al-Kali, A., Baer, M. R., Sekeres, M., Roboz, G., Gaidano, G., Scott, B., Greenberg, P., Platzbecker, U., Steensma, D. P., Kambhampati, S., Kreuzer, K. A., Godley, L., Collins, R., Atallah, E., Azarnia, N., Petrone, M. E., Snyder, B. R., Maniar, M. and Silverman, L. R. (2015). RANDOMIZED PHASE III STUDY OF IV RIGOSERTIB VERSUS BEST SUPPORTIVE CARE (BSC) IN PATIENTS WITH HIGHER-RISK MDS (HR-MDS) AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS). Leuk. Res., 39. S. S57 - 2. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1873-5835

Garcia-Manero, G., Fenaux, P., Al-Kali, A., Baer, M. R., Sekeres, M., Roboz, G., Gaidano, G., Scott, B., Greenberg, P., Platzbecker, U., Steensma, D. P., Kambhampati, S., Kreuzer, K. A., Godley, L., Collins, R., Atallah, E., Azarnia, N., Petrone, M. E., Snyder, B. R., Maniar, M. and Silverman, L. R. (2015). RANDOMIZED PHASE III STUDY OF IV RIGOSERTIB VERSUS BEST SUPPORTIVE CARE (BSC) IN PATIENTS WITH HIGHER-RISK MDS (HR-MDS) AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS). Leuk. Res., 39. S. S57 - 2. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1873-5835

Heidenreich, S., Zabelina, T., van Biezen, A., Finke, J., Platzbecker, U., Niederwieser, D., Einsele, H., Bethge, W., Schwerdtfeger, R., Beelen, D., Tischer, J., Nagler, A., Zachee, P., Scheid, C., de Witte, T., Robin, M. and Kroger, N. (2015). Allogeneic stem cell transplantation for MDS patients more than 70 years of age. A report of MDS subcommittee of CMWP of EBMT. Bone Marrow Transplant., 50. S. S305 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Heidenreich, S., Zabelina, T., van Biezen, A., Finke, J., Platzbecker, U., Niederwieser, D., Einsele, H., Bethge, W., Schwerdtfeger, R., Beelen, D., Tischer, J., Nagler, A., Zachee, P., Scheid, C., de Witte, T., Robin, M. and Kroger, N. (2015). Allogeneic stem cell transplantation for MDS patients more than 70 years of age. A report of MDS subcommittee of CMWP of EBMT. Bone Marrow Transplant., 50. S. S305 - 2. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Hoechsmann, B., Leichtle, R., Roeth, A., Panse, J., Haferlach, T., Borchmann, P., Aulitzky, W. E., Dengler, J., Port, M., Platzbecker, U., Klausmann, M., Steinmetz, T., Becker, M., Schmidt, B. and Schrezenmeier, H. (2015). Data from German centers in the global PNH Patient Registry-analysis of the translation of the DGHO-guidelines for the treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in real life therapy. Oncol. Res. Treat., 38. S. 105 - 107. BASEL: KARGER. ISSN 2296-5262

Jawharl, M., Naumann, N., Schwaab, J., Dietz, C., Casper, J., Dang, T. A., Dietze, L., Doehner, K., Haenel, A., Lathan, B., Link, H., Lotfti, S., Mielkel, S., Luber, V., Maywald, O., Mueller, L., Platzbecker, U., Pruemmer, O., Thomssen, H., Toepelt, K., Schmitt, K., Baurmann, H., Vielert, T., Hofmann, W. K., Haferlach, C., Cross, N. C., Fabarius, A., Reiter, A. and Metzgeroth, G. (2016). CLINICAL CHARACTERISTICS AND LONG-TERM OUTCOME ON IMATINIB IN PATIENTS WITH MYELOID/LYMPHOID NEOPLASMS AND ASSOCIATED PDGFRB FUSION GENES IN CHRONIC OR BLAST PHASE. Haematologica, 101. S. 264 - 266. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Kroeger, N., Brand, R., Niederwieser, D., Platzbecker, U., Huebel, K., Weber, T., Robin, M., Stelljes, M., Afanasiev, B., Heim, D., Deliliers, G. Lambertenghi, Onida, F., Dreger, P., Pini, M., Guidi, S., Volin, L., Gramatzki, M., Bethge, W., Poire, X., Kobbe, G., van Os, M., Iacobelli, S. and de Witte, T. (2015). RIC vs. MAC followed by allogeneic stem cell transplantation for patients with MDS or secondary AML: A prospective, randomized phase III study of the CMWP of the EBMT (RICMAC-Trial). Bone Marrow Transplant., 50. S. S5 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Kroeger, N., Brand, R., Niederwieser, D., Platzbecker, U., Huebel, K., Weber, T., Robin, M., Stelljes, M., Afanasiev, B., Heim, D., Deliliers, G. Lambertenghi, Onida, F., Dreger, P., Pini, M., Guidi, S., Volin, L., Gramatzki, M., Bethge, W., Poire, X., Kobbe, G., van Os, M., Iacobelli, S. and de Witte, T. (2015). RIC vs. MAC followed by allogeneic stem cell transplantation for patients with MDS or secondary AML: A prospective, randomized phase III study of the CMWP of the EBMT (RICMAC-Trial). Bone Marrow Transplant., 50. S. S5 - 1. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5365

Platzbecker, U. (2015). Therapy in MDS. Oncol. Res. Treat., 38. S. 87 - 88. BASEL: KARGER. ISSN 2296-5262

Roeth, A., Raiser, C., Panse, J., Steinbach, Cicalo F., Sockel, K., Haferlach, T., Huebel, K., Blau, I. W., Casper, J., Platzbecker, U., Ganser, A., Hoechsmann, B. and Schrezenmeier, H. (2020). Changes in the burden of disease in treated and untreated patients in the German cohort of the International Registry of Paroxysmal Nocturnal Hemoglobinuria (PNH) - a 2020 Update. Oncol. Res. Treat., 43 (SUPPL 4). S. 174 - 175. BASEL: KARGER. ISSN 2296-5262

Silverman, L., Fenaux, P., Al-Kali, A., Baer, M., Sekeres, M., Roboz, G., Gaidano, G., Scott, B., Greenberg, P., Platzbecker, U., Steensma, D., Kreuzer, K. -A., Godley, L., Collins, R., Atallah, E., Azarnia, N. and Garcia-Manero, G. (2015). PROGNOSTIC AND PREDICTIVE VALUE OF IPSS-R IN ASSESSING OVERALL SURVIVAL (OS) IN A PHASE III STUDY OF RIGOSERTIB IN SECOND-LINE HIGHER-RISK (HR) MDS PATIENTS. Haematologica, 100. S. 492 - 493. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Silverman, L. R., Fenaux, P., Al-Kali, A., Baer, M. R., Sekeres, M., Roboz, G., Gaidano, G., Scott, B., Greenberg, P., Platzbecker, U., Steensma, D. P., Kambhampati, S., Kreuzer, K. A., Godley, L., Collins, R., Atallah, E., Navada, S. C., Azarnia, N. and Garcia-Manero, G. (2015). BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION? Leuk. Res., 39. S. S44 - 2. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1873-5835

Silverman, L. R., Fenaux, P., Al-Kali, A., Baer, M. R., Sekeres, M., Roboz, G., Gaidano, G., Scott, B., Greenberg, P., Platzbecker, U., Steensma, D. P., Kambhampati, S., Kreuzer, K. A., Godley, L., Collins, R., Atallah, E., Navada, S. C., Azarnia, N. and Garcia-Manero, G. (2015). BONE MARROW BLAST (BMBL) RESPONSE CORRELATES WITH OVERALL SURVIVAL IN RIGOSERTIB-TREATED PATIENTS WITH HIGHER-RISK MDS AFTER FAILURE OF HYPOMETHYLATING AGENTS (HMAS): A NEW RESPONSE CRITERION? Leuk. Res., 39. S. S44 - 2. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 1873-5835

Sockel, K., Frank, S., Neu, A., Ditschkowski, M., Hilgendorf, I., Goeckenjan, M., Stoelzel, F., Middeke, J. M., Kroeger, N., Ayuketang, Ayuk F., Eder, M., Bethge, W., Finke, J., Bertz, H., Kobbe, G., Kaufmann, M., Platzbecker, U., Beverungen, D., Schmid, C., von Bonin, M., Heberling, L., Teipel, R., Bug, G., Fraccaroli, A., Tischer, J., Holler, B., Wolff, D., Luft, T., Roesler, W., Schaefer-Eckart, K., Dressler, S., Scheid, C., Holtick, U., Klein, S., Blau, I. -W., Burchert, A., Wulf, G., Hasenkamp, J., Kaun, S., Wittke, C., Wortmann, F., Bornhaeuser, M. and Schetelig, J. (2020). Evaluation of pregnancies after allogeneic stem cell transplantation during the last 15years in Germany. Oncol. Res. Treat., 43 (SUPPL 4). S. 240 - 241. BASEL: KARGER. ISSN 2296-5262

This list was generated on Fri Mar 29 15:44:05 2024 CET.